Related Experiment Video

Updated: Aug 13, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer

Judith N Kloth1, Gert Jan Fleuren, Jan Oosting

  • 1Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. J.N.Kloth@lumc.nl

Carcinogenesis
|May 10, 2005
PubMed

Insights

Transforming growth factor-beta 1 (TGF-beta1) inhibits cell growth, but cervical cancer cells develop resistance. This study reveals how TGF-beta1 affects gene expression in cancer cells, impacting tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Transforming growth factor-beta 1 (TGF-beta1) normally inhibits epithelial cell proliferation.
  • Cervical carcinoma development involves increased TGF-beta1 production and decreased cell sensitivity to its growth-limiting effects.
  • TGF-beta1 can also suppress immune cells, potentially aiding tumor progression.

Purpose of the Study:

  • To investigate the effect of TGF-beta1 on mRNA expression profiles in cervical carcinoma cell lines with varying sensitivities.
  • To identify genes and pathways involved in cell growth and death that are modulated by TGF-beta1.
  • To understand the molecular mechanisms underlying TGF-beta1 resistance in cervical cancer.

Main Methods:

  • Gene expression profiling using microarray analysis of 8973 genes in CC10B, SiHa, and HeLa cervical cancer cell lines.
  • Stimulation of cell lines with TGF-beta1 at multiple time points (0, 6, 12, 24 hours).
  • Validation of gene expression changes using quantitative real-time PCR and measurement of TGF-beta1 production via ELISA.

Main Results:

  • Novel target genes in tumor necrosis factor alpha (TNFalpha), mitogen-activated protein kinase (MAPK), and wingless type (Wnt) pathways were identified in response to TGF-beta1.
  • Significant differences in gene expression were observed between TGF-beta1 sensitive and insensitive cell lines within TNFalpha, MAPK, Wnt, and Smad pathways.
  • Increased resistance to TGF-beta1's growth inhibition correlated with higher endogenous TGF-beta1 production by the cell lines.

Conclusions:

  • The identified pathways (TNFalpha, MAPK, Wnt, Smad) are crucial in determining cellular sensitivity to TGF-beta1-induced growth inhibition.
  • TGF-beta1 resistance in cervical cancer is linked to elevated autocrine TGF-beta1 production.
  • Tumor cell TGF-beta1 excretion may promote tumor development through paracrine signaling rather than direct autocrine inhibition.

More Related Videos

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...